IRIS
Grimaldi, Luigi Maria Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 808
SA - Sud America 396
NA - Nord America 279
EU - Europa 148
AF - Africa 26
Totale 1.657
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 568
BR - Brasile 368
US - Stati Uniti d'America 213
HK - Hong Kong 76
MX - Messico 45
IT - Italia 36
GB - Regno Unito 31
BD - Bangladesh 28
FR - Francia 25
VN - Vietnam 23
CN - Cina 20
DE - Germania 19
IN - India 18
IQ - Iraq 18
UA - Ucraina 12
CA - Canada 11
SA - Arabia Saudita 11
TR - Turchia 11
PK - Pakistan 10
ZA - Sudafrica 10
CO - Colombia 7
RU - Federazione Russa 7
EC - Ecuador 6
UZ - Uzbekistan 6
JM - Giamaica 5
KE - Kenya 5
NL - Olanda 5
VE - Venezuela 5
EG - Egitto 4
MA - Marocco 4
NP - Nepal 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
ES - Italia 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
KZ - Kazakistan 2
OM - Oman 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
ET - Etiopia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
KN - Saint Kitts e Nevis 1
PL - Polonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
SE - Svezia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 1.657
Salva come PNG Salva come JPEG
Città #
Singapore 332
Hong Kong 71
Mexico City 40
São Paulo 27
Rome 21
Beijing 17
Rio de Janeiro 17
New York 13
Brasília 10
Baghdad 8
Belo Horizonte 8
Dallas 8
Dhaka 8
Ho Chi Minh City 8
Secaucus 7
Campinas 6
Frankfurt am Main 6
Goiânia 6
Bexley 5
Nairobi 5
Ourinhos 5
Tashkent 5
Boydton 4
Chicago 4
Curitiba 4
Duque de Caxias 4
Guarulhos 4
Hanoi 4
Jeddah 4
Kingston 4
Milan 4
Nova Iguaçu 4
Porto Alegre 4
Recife 4
Ashburn 3
Cape Town 3
Chapecó 3
Contagem 3
Dammam 3
Houston 3
Istanbul 3
Johannesburg 3
Juiz de Fora 3
Karachi 3
Lima 3
Lucknow 3
Manaus 3
Quito 3
Riyadh 3
Santo André 3
São José dos Campos 3
São Vicente 3
Uberlândia 3
Varginha 3
Amparo 2
Atibaia 2
Atlanta 2
Beachwood 2
Bento Gonçalves 2
Betim 2
Birmingham 2
Blumenau 2
Bragança Paulista 2
Bristol 2
Brooklyn 2
Canoas 2
Carapicuíba 2
Caruaru 2
Casablanca 2
Catalão 2
Caxias do Sul 2
Cleveland 2
Da Nang 2
Denver 2
Dubai 2
Duhok 2
Elkridge 2
Feira de Santana 2
Fortaleza 2
Ipatinga 2
Itabira 2
Jacksonville 2
Juazeiro do Norte 2
Kathmandu 2
Kingsland 2
Lençóis Paulista 2
Limeira 2
London 2
Magé 2
Maricá 2
Maringá 2
Marília 2
Mauá 2
Medellín 2
Melzo 2
Montreal 2
Mosul 2
Natal 2
Olímpia 2
Parnamirim 2
Totale 833
Salva come PNG Salva come JPEG
Nome #
Cytokines and immunity in multiple sclerosis: The dual signal hypothesis 157
An Italian programme for COVID-19 infection in multiple sclerosis 13
18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification 13
Absence of engraftment of lymphoid organs in hu-PBL SCID mice: a study employing fluorescent in situ hybridization (FISH) for the identification of human cells 12
Rivastigmine may be helpful for the dementia of Parkinson's disease 12
Natalizumab in pediatric multiple sclerosis: Results of a cohort of 55 cases 12
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 12
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination 12
The italian pharmacovigilance program: An observational study of adverse effects of natalizumab in multiple sclerosis therapy 12
Multiple Sclerosis Progression and Relapse Activity in Children 12
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification 11
Longitudinal changes in social functioning in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II) 11
The pervasiveness of interleukin-1 in Alzheimer pathogenesis: A role for specific polymorphisms in disease risk 11
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study 11
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymerc mixture, in patients with relapsing-remitting multiple sclerosis 11
Soluble interleukin-1 receptor antagonist intron 2 polymorphism is associated with occurrence and clinical disability in patients with multiple sclerosis 10
Discontinuous distribution of IgG oligoclonal bands in cerebrospinal fluid from multiple sclerosis patients 10
Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register 10
Improved conditions for the analysis of large variable number of tandemly repeated (VNTR) unit polymorphisms 10
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 10
Reply 10
Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis 10
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 10
A novel missense mutation (L219F) in exon 8 of the preselinin 1 gene in an Italian family with presenile familial Alzheimer's disease 10
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population 10
Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: Relation to insulin-dependent diabetes mellitus and islet cell antibodies 10
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 10
Analysis of an IFN-γ gene (IFNG) polymorphism in multiple sclerosis in Europe: Effect of population structure on association with disease 9
Reply 9
Genetica e neurodegenerazione: nuove prospettive terapeutiche per il morbo di Alzheimer? 9
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study) 9
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: A randomised, controlled phase 3 trial 9
Radiomics Analysis of Brain [18 F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis 9
The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome in patients 9
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 9
Identification of peptides binding to IgG in the CSF of multiple sclerosis patients 9
Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1α 9
Clinical and immunological relevance of the γ-IFN-activated Ca2+ influx present in MS patients 9
Anti-inflammatory and cognitive effects of interferon-?1a (IFN?1a) in a rat model of Alzheimer's disease 9
γ-interferon activates a new Ca2+ influx in T-lymphocytes from multiple sclerosis patients 9
Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis 9
Immunity and the Stiff-man syndrome: Pathogenetic Problems 9
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 9
Stiff-man syndrome in a patient with Hodgkin's disease. An unusual paraneoplastic syndrome 9
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study 9
Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome 9
Relevance of an intronic polymorphism in myasthenia gravis: a preliminary study 9
Association of early onset Alzheimer's disease with an interleukin-1 α polymorphism 8
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 8
Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients 8
The interleukin 1-β exonic (+3953) polymorphism does not alter in vitro protein secretion 8
A polymorphism in the interleukin-1α gene influences the clinical features of migraine 8
Genetic heterogeneity in Italian families with familial hemiplegic migraine 8
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 8
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 8
SOLUBLE INTERLEUKIN-1 RECEPTOR ANTAGONIST INTRON 2 POLYMORPHISM: FUNCTIONAL ROLE AND RELEVANCE IN MULTIPLE SCLEROSIS 8
Restricted heterogeneity of antibody to gp120 and p24 in AIDS 8
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study 8
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis 8
Efficacy of vitamin D 3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, doubble-blind, randomized, placebo-controlled trial 8
A new model of HTLV-I neurotropism and lymphoid tumorigenesis in the SCID mouse 8
Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients 8
γ Interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis 8
Signs and symptoms of COVID-19 in patients with multiple sclerosis 8
Glucocorticoid-related genetic susceptibility for Alzheimer's disease 8
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study 8
Oligoclonal bands in the cerebrospinal fluid of post-poliomyelitis muscular atrophy ( Reply To Lassman H and to Dalakas M) 8
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries 8
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial 8
Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases 8
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial 8
Studio comparativo TC ed RM di un caso di cisticercosi cerebrale 8
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study 8
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 8
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 7
Pharmacogenomics of neurodegenerative diseases 7
Heterogeneity of autoantibodies in stiff-man syndrome 7
A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects 7
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 7
Does hemispheric dominance influence brain lesion distribution in multiple sclerosis? 7
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective 7
Absence of central nervous system pathology in severe combined immunodeficiency mice intraperitoneally injected with peripheral blood lymphocytes from multiple sclerosis patients 7
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis 7
Silver nitrate staining of unconcentrated cerebrospinal fluid proteins. Clinico-statistical analysis of 53 neurology patients | Colorazione con nitrato d'argento delle proteine del liquido cefalorachidiano non concentrato. Analisi clinico-statistica su 53 pazienti neurologici 7
Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with alzheimers disease: A prospective, observational study 7
L'utilizzo del topo SCID per la creazione di nuovi modelli sperimentali chimerici di miastenia gravis 7
Intracellular Ca2+ stores of T lymphocytes: Changes induced by in vitro and in vivo activation 7
Ctla4 and multiple sclerosis in the Italian population 7
Genetic association of acyl-coenzyme A: Cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease 7
Genetic burden of common variants in progressive and bout-onset multiple sclerosis 7
Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis 7
The human-myasthenic mouse chimera: a new approach to study myasthenia gravis (MG) 7
HTLV-I hu-SCID mouse in the study of HTLV-I neurotropism 7
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study 7
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension 7
Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, Northern Italy, Sardinia and Sweden 7
Association study of the HLA-A2 allele in Italian Alzheimer disease patients 7
The molecular anatomy of human Hps60 and its similarity with that of bacterial orthologs and acetylcholine receptor reveal a potential patogenetic role of anti-chaperonin immunity in myasthenia gravis 7
Prion protein gene polymorphism and Alzheimer's disease: One modulatory trait of cognitive decline? [2] 7
The Italian multiple sclerosis register 7
Totale 1.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.694 0 0 0 0 0 0 54 151 135 163 530 661
2025/2026309 309 0 0 0 0 0 0 0 0 0 0 0
Totale 2.003